Rhofade, Oxymetazoline Cream 1% for the redness of Rosacea

Rhofade is Allergan’s Oxymetazoline based topical treatment for the red face of rosacea. Rhofade is known chemically as a Selective α1-Adrenergic Receptor Agonist, and during the drug’s development was known as AGN-199201 and also V-101.

Recent Rosacea Blog Posts

Mirvaso and Rhofade are very different indeed

Some laboratory based research has for the first time given us a highly detailed view of the method of action of 2 recently approved treatments for the redness of rosacea. The two treatments, brimonidine based Mirvaso, and oxymetazoline based Rhofade differ have been shown by this research to greatly their method of action. Although brimonidine […]

Continue Reading

Rhofade may come with a heart valve damage risk

A recently published paper that seeks to compare the actions of oxymetazoline (Rhofade) and brimonidine (Mirvaso) has raised a possible safety issue with the action of oxymetazoline. The paper states the safety issue as; As the 5-HT2B receptor is potentially involved in drug-induced valvulopathy, the benefit/risk ratio (of Rhofade ed.) should be carefully considered, especially in […]

Continue Reading

Rhofade as an adjunct to IPL, PDL and KTP Laser

Allergan is sponsoring a clinical trial to evaluate whether their oxymetazoline HCL 1% based treatment – Rhofade, is an effective adjunctive treatment for rosacea patients undergoing treatments with Pulse Dye Laser (PDL), Intense Pulsed Light (IPL) or KTP Laser. The trial is designated as a Safety and Tolerability measure, so researchers will be looking for […]

Continue Reading

Rhofade wins Allure’s `Breakthrough Product’ Award

Rhofade has achieved some publicity through an award from Allure, the well known beauty magazine brand. The award is called the Allure Beauty Breakthrough Award and was  given for `making great strides in educating media and consumers about ongoing facial redness due to rosacea’. Rhofade seems to be generally liked by rosacea sufferers – see Rhofade User Reviews […]

Continue Reading

Allergan will be pleased to discover that they scored a free (one presumes) mention of their Rhofade product in the New York Times Fashion & Style section today. Given that Rhofade is a prescription item, this amounts to publicity of the sort that they cannot buy. How to Go Makeup-Free This Summer By CRYSTAL MARTIN AUG. 1, […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.